Phylloed tumor in details

Reading File

Finding Sources

Reading File

Loading Image

I now have comprehensive, well-sourced information from multiple authoritative surgical and pathology textbooks. Here is a detailed overview of phyllodes tumor:

Phyllodes Tumor

Definition & Overview

Phyllodes tumor is a fibroepithelial neoplasm of the breast arising from the intralobular stroma. The name comes from the Greek phyllodes ("leaf-like"), describing the characteristic gross and histologic appearance of leaf-like projections. It was historically called cystosarcoma phyllodes, a misnomer now largely abandoned because the majority of cases follow a benign course.

It accounts for <1–2.5% of all fibroepithelial breast lesions and is therefore uncommon.

Pathogenesis & Molecular Biology

Like fibroadenomas, the majority of phyllodes tumors carry mutations in:

MED12 (part of the transcriptional regulator mediator complex)
RARA (retinoic acid receptor alpha)

This shared mutational profile suggests a shared pathogenesis with fibroadenoma. However, phyllodes tumors are more likely to harbor additional driver mutations that distinguish them:

TERT (telomerase gene) — associated with malignant transformation
TP53 — tumor suppressor loss
RB — cell cycle regulator loss

A key molecular distinction: stromal cells of fibroadenomas may be polyclonal or monoclonal, whereas those of phyllodes tumors are always monoclonal, confirming their neoplastic nature.

— Robbins, Cotran & Kumar Pathologic Basis of Disease

Gross Pathology

Tumors vary from a few centimeters to massive lesions that may occupy the entire breast
The cut surface shows bulbous, leaf-like protrusions — nodules of proliferating stroma covered by epithelium extending into cystic spaces
Connective tissue composes the bulk of the tumor, with mixed gelatinous, solid, and cystic areas
Cystic areas represent sites of infarction and necrosis
The tumor is usually sharply demarcated from surrounding compressed breast tissue

Clinical photo — Malignant phyllodes tumor (cystosarcoma phyllodes):

Malignant phyllodes tumor — gross clinical appearance showing massive breast enlargement

Histopathology

The defining histologic feature is a biphasic proliferation of stroma and mammary epithelium, with elongated epithelium-lined clefts creating the leaf-like architecture.

Histologic grading is based entirely on stromal features:

Grade	Features
Benign	Cellular stroma, mildly increased mitotic activity; resembles fibroadenoma but more cellular
Borderline	More prominent stromal atypia, increased cellularity, and mitotic activity
Malignant	Widely infiltrative, marked stromal overgrowth with few residual epithelial elements; may be indistinguishable from pure sarcoma

Malignant phyllodes tumors often contain liposarcomatous or rhabdomyosarcomatous elements rather than fibrosarcomatous elements. The number of mitoses and presence of invasive foci at the tumor margin help identify malignancy.

Histology — Malignant phyllodes tumor (H&E ×100):

Histologic features of malignant phyllodes tumor showing leaf-like epithelial-lined clefts within hypercellular stroma (H&E ×100)

— Schwartz's Principles of Surgery, 11th Ed.

Clinical Features

Feature	Details
Age	Peak in the 5th–6th decade (10–20 years later than fibroadenoma)
Sex	Almost exclusively females
Presentation	Firm, lobulated, palpable mass; average size ~5 cm
Growth	Can be slow or rapidly growing
Suspicious features vs. fibroadenoma	Size >3 cm, rapid growth, older patient

Up to 75% are benign cytologically.

Diagnosis

Mammography: May show calcifications; cannot reliably distinguish benign from malignant, or from fibroadenoma
Core needle biopsy (CNB): Preferred over fine-needle cytology; however, classifying grade on limited sampling is difficult — a CNB reported as "cellular fibroepithelial lesion" could represent either fibroadenoma or phyllodes tumor
Excisional biopsy: Gold standard for definitive diagnosis and grading when CNB is equivocal

— Sabiston Textbook of Surgery; Berek & Novak's Gynecology

Behavior & Prognosis

Grade	Local Recurrence	Metastasis	Notes
Benign	Occasional	None	Margin status is the key predictor of recurrence
Borderline	Increased risk	Rare	Greater potential than benign
Malignant	High	~1/3 of cases (hematogenous)	Metastases contain only stromal component

Lymph node spread is rare regardless of grade
Metastases occur via hematogenous spread, most commonly to the lungs
Most recurrences occur within the first 2 years after excision

— Robbins, Cotran & Kumar; Sabiston Textbook of Surgery

Management

Surgery (Cornerstone)

Grade	Surgery
Benign	Local/excisional biopsy with clear margins — curative (similar to fibroadenoma)
Borderline / Malignant	Wide local excision with ≥1–2 cm margins to reduce local recurrence
Large tumors	Total mastectomy may be required when tumor size is disproportionate to breast size

Axillary lymph node dissection is contraindicated — lymphatic spread is exceedingly rare and axillary staging is not indicated

Adjuvant Therapy

Radiation: May be considered for borderline or malignant phyllodes undergoing breast-conserving surgery
Chemotherapy: For metastatic malignant phyllodes — treated as sarcoma (limited benefit); common regimens follow sarcoma protocols

Follow-Up

Close surveillance with physical examination and imaging, especially in the first 2 years post-excision

— Sabiston Textbook of Surgery; Schwartz's Principles of Surgery; Mulholland & Greenfield's Surgery

Phyllodes vs. Fibroadenoma — Key Distinctions

Feature	Fibroadenoma	Phyllodes Tumor
Age	20s–30s	40s–60s
Size	Usually <3 cm	Often >3 cm
Growth	Slow	Can be rapid
Stroma	Less cellular, polyclonal or monoclonal	Always monoclonal, more cellular
TERT/TP53/RB mutations	Absent	Present in malignant forms
Behavior	Benign, no excision required	Excision always required
Axillary spread	None	Rare but possible (malignant)

Sources:

Robbins, Cotran & Kumar — Pathologic Basis of Disease
Schwartz's Principles of Surgery, 11th Ed.
Sabiston Textbook of Surgery
Mulholland & Greenfield's Surgery, 7th Ed.
Berek & Novak's Gynecology

This is a shared conversation. Sign in to Orris to start your own chat.